Oppenheimer & Co Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$30M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$16.2M |
| 3 |
iShares Russell 2000 Value ETF
IWN
|
+$10.6M |
| 4 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$7.95M |
| 5 |
IBM
IBM
|
+$5.84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TLOG
TetraLogic Pharmaceuticals Corporation
TLOG
|
+$10.2M |
| 2 |
Vanguard High Dividend Yield ETF
VYM
|
+$8.32M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$7.79M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$5.38M |
| 5 |
Kimberly-Clark
KMB
|
+$5.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.94% |
| 2 | Healthcare | 10.62% |
| 3 | Industrials | 9.8% |
| 4 | Technology | 9.43% |
| 5 | Financials | 9.07% |
Similar funds
Oppenheimer & Co's Q1 2014 Portfolio in Review
As of Q1 2014, Oppenheimer & Co held 1,564 positions worth $3.34B, up 6.7% from $3.13B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Oppenheimer & Co deployed $157M of net new capital in Q1 2014, opening 189 new positions and adding to 576 existing holdings. Its largest new stake was Vanguard Total Stock Market ETF: 169,083 shares worth $16.5M.
By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 12% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Vanguard Dividend Appreciation ETF, an estimated $7.79M trimmed.
- Oppenheimer & Co's largest Q1 2014 buy was Vanguard Total Stock Market ETF: 169,083 shares worth $16.5M.
- Oppenheimer & Co added most to Monsanto Co in Q1 2014, an estimated $30M increase.
- Oppenheimer & Co's biggest Q1 2014 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $7.79M.
- Oppenheimer & Co fully exited TetraLogic Pharmaceuticals Corporation in Q1 2014, selling an estimated $10.2M.
- Oppenheimer & Co's ten largest holdings make up 12% of its $3.34B portfolio in Q1 2014.
- Oppenheimer & Co opened 189 new positions and closed 163 in Q1 2014.
- Oppenheimer & Co's portfolio value rose 6.7% quarter-over-quarter to $3.34B.
Based on Oppenheimer & Co's 13F filing for Q1 2014, filed 9 May 2014.